Eye tracking for wet AMD recovery at home
Part of Eyes & vision clinical trials.
This study tests a web-based system that uses eye tracking to check vision in people being treated for wet age-related macular degeneration (AMD). It may help monitor your recovery without needing as many clinic visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 55 and 99 years old.
- You are currently being treated for wet AMD and have no signs of active disease.
- You can follow spoken instructions in English, Chinese, or Malay.
- You can turn on your computer and connect it to the study's web platform.
- You have not had eye surgery in the last 3 months or vitrectomy in the last 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses eye imaging and other tests to predict if early age-related macular degeneration (AMD) will progress to a more advanced stage. It aims to help doctors identify who might need closer monitoring in the future.
This study looks at eye fluid from people with untreated wet AMD to find out why some don't respond well to standard injections. The goal is to improve future treatments.
This study uses a special camera to take pictures of the back of your eye (retina) to see how age-related macular degeneration (AMD) affects everyday activities like reading and recognizing faces. It also compares people with AMD to healthy volunteers to understand the differences.
This trial uses artificial intelligence to track changes in the eyes of people with advanced age-related macular degeneration (AMD) that has caused a specific type of damage (atrophy) in the retina. The goal is to see if AI can help detect when the disease gets worse, so doctors can personalize monitoring for each patient.
This study tests a quick, noninvasive eye test that measures how well you see in the dark, which can be an early sign of dry AMD. Researchers want to see if the test relates to everyday tasks like reading or driving at night.
This study uses artificial intelligence to track changes in the eyes of people with early or intermediate age-related macular degeneration (AMD). It aims to better understand how the disease progresses and may help doctors personalize care.
Hear when a new Age-Related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.